BioMAS Ltd.
๐ฎ๐ฑIsrael
Safety and Efficacy Double Blind Vehicle Controlled Study of 15% AS101 Gel to Treat External Genital Warts
Phase 2
- Conditions
- External Genital Warts
- Interventions
- Drug: 15% AS101 gelDrug: Vehicle
- First Posted Date
- 2013-09-17
- Last Posted Date
- 2016-11-01
- Lead Sponsor
- BioMAS Ltd
- Target Recruit Count
- 60
- Registration Number
- NCT01943630
- Locations
- ๐ฎ๐ฑ
Kaplan Medical Center, Department of Gynecology, Rehovot, Israel
๐ฎ๐ฑHa'Emek Medical Center, Department of Gynecology and obstetrics, Afula, Israel
๐ฎ๐ฑZiv Medical Center, Department of Gynecology and obstetrics, Safed, Israel
Safety and Efficacy Study to Test Topical AS101 for External Genital Warts
Phase 1
Completed
- Conditions
- Wart; External Genital OrgansCondyloma Acuminata
- Interventions
- Drug: Topical AS101
- First Posted Date
- 2012-03-15
- Last Posted Date
- 2013-08-15
- Lead Sponsor
- BioMAS Ltd
- Target Recruit Count
- 12
- Registration Number
- NCT01555112
- Locations
- ๐ฎ๐ฑ
Gynecology department, Haemek MC, Afula, Israel
Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients
- First Posted Date
- 2009-11-10
- Last Posted Date
- 2015-02-10
- Lead Sponsor
- BioMAS Ltd
- Target Recruit Count
- 12
- Registration Number
- NCT01010373
- Locations
- ๐ฎ๐ฑ
Sheba Medical Center, Tel Hashomer, Israel
Topical Application of AS101 for the Treatment of Atopic Dermatitis
Phase 2
Terminated
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: AS101 ointment
- First Posted Date
- 2009-06-24
- Last Posted Date
- 2014-07-17
- Lead Sponsor
- BioMAS Ltd
- Target Recruit Count
- 5
- Registration Number
- NCT00927212
- Locations
- ๐ฎ๐ฑ
Dermatology department, Sheba Medical Center, Ramat-Gan, Israel
Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor Patients
- First Posted Date
- 2009-06-23
- Last Posted Date
- 2011-06-21
- Lead Sponsor
- BioMAS Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT00926354
- Locations
- ๐ฎ๐ฑ
Meir Medical Center, Kfar Saba, Israel
Topical Application of AS101 for the Treatment of Psoriasis
Phase 2
Withdrawn
- Conditions
- Mild to Moderate Psoriasis
- Interventions
- Drug: AS101 Cream
- First Posted Date
- 2008-11-11
- Last Posted Date
- 2015-07-23
- Lead Sponsor
- BioMAS Ltd
- Registration Number
- NCT00788424
- Locations
- ๐ฎ๐ฑ
Hadassah Medical Organization, Jerusalem, Israel
ยฉ Copyright 2025. All Rights Reserved by MedPath